Urine drug screening: practical guide for clinicians KE Moeller, KC Lee, JC Kissack Mayo clinic proceedings 83 (1), 66-76, 2008 | 708 | 2008 |
Pharmacotherapy principles and practice MA Chisholm-Burns, TL Schwinghammer, PM Malone, JM Kolesar, ... McGraw-Hill, 2022 | 295 | 2022 |
Clinical interpretation of urine drug tests: what clinicians need to know about urine drug screens KE Moeller, JC Kissack, RS Atayee, KC Lee Mayo Clinic Proceedings 92 (5), 774-796, 2017 | 229 | 2017 |
A longitudinal analysis of nurse suicide in the United States (2005–2016) with recommendations for action JE Davidson, J Proudfoot, K Lee, G Terterian, S Zisook Worldviews on Evidence‐Based Nursing 17 (1), 6-15, 2020 | 180 | 2020 |
Assessment of burnout and associated risk factors among pharmacy practice faculty in the United States SY El-Ibiary, L Yam, KC Lee American journal of pharmaceutical education 81 (4), 75, 2017 | 176 | 2017 |
Web-based tools and mobile applications to mitigate burnout, depression, and suicidality among healthcare students and professionals: a systematic review S Pospos, IT Young, N Downs, A Iglewicz, C Depp, JY Chen, I Newton, ... Academic psychiatry 42, 109-120, 2018 | 173 | 2018 |
Human iPSC neurons display activity-dependent neurotransmitter secretion: aberrant catecholamine levels in schizophrenia neurons V Hook, KJ Brennand, Y Kim, T Toneff, L Funkelstein, KC Lee, M Ziegler, ... Stem cell reports 3 (4), 531-538, 2014 | 130 | 2014 |
Nurse suicide in the United States: Analysis of the center for disease control 2014 national violent death reporting system dataset JE Davidson, J Proudfoot, K Lee, S Zisook Archives of psychiatric nursing 33 (5), 16-21, 2019 | 120 | 2019 |
HLA-B* 5701 testing to predict abacavir hypersensitivity JD Ma, KC Lee, GM Kuo PLoS currents 2, 2010 | 89 | 2010 |
Tamoxifen treatment and new-onset depression in breast cancer patients KC Lee, GT Ray, EM Hunkeler, PR Finley Psychosomatics 48 (3), 205-210, 2007 | 85 | 2007 |
Pharmacotherapy considerations in patients with HIV and psychiatric disorders: focus on antidepressants and antipsychotics L Hill, KC Lee Annals of Pharmacotherapy 47 (1), 75-89, 2013 | 84 | 2013 |
Individuals with a gifted/attention deficit/hyperactivity disorder diagnosis: Identification, performance, outcomes, and interventions KM Lee, FR Olenchak Gifted Education International 31 (3), 185-199, 2015 | 78 | 2015 |
Clinical application of pharmacogenomics JD Ma, KC Lee, GM Kuo Journal of pharmacy practice 25 (4), 417-427, 2012 | 74 | 2012 |
Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory T Makunts, S Alpatty, KC Lee, RS Atayee, R Abagyan Scientific reports 9 (1), 17280, 2019 | 73 | 2019 |
Depression, antidepressants and driving safety LL Hill, VL Lauzon, EL Winbrock, G Li, S Chihuri, KC Lee Injury epidemiology 4, 1-10, 2017 | 70 | 2017 |
Transdermal selegiline for the treatment of major depressive disorder KC Lee, JJ Chen Neuropsychiatric disease and treatment 3 (5), 527-537, 2007 | 67 | 2007 |
Patterns of stress, coping and health-related quality of life in doctor of pharmacy students JD Hirsch, P Nemlekar, P Phuong, KA Hollenbach, KC Lee, DS Adler, ... American journal of pharmaceutical education 84 (3), 7547, 2020 | 65 | 2020 |
Pharmacogenomics: bridging the gap between science and practice KC Lee, JD Ma, GM Kuo Journal of the American Pharmacists Association 50 (1), e1-e17, 2010 | 62 | 2010 |
Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings KC Lee, PR Finley, BK Alldredge Expert opinion on drug safety 2 (3), 233-247, 2003 | 62 | 2003 |
Adherence to antipsychotics among Latinos and Asians with schizophrenia and limited English proficiency TP Gilmer, VD Ojeda, C Barrio, D Fuentes, P Garcia, NM Lanouette, ... Psychiatric Services 60 (2), 175-182, 2009 | 55 | 2009 |